17 May 2022
ANANDA
DEVELOPMENTS PLC
(“Ananda” or the “Company”)
EXERCISE OF
WARRANTS
Ananda announces that 5,178,240 ordinary shares of 0.2p each in
the Company (“Ordinary Shares”) have been issued following the
exercise of warrants at 0.45p per share. The proceeds received by
the Company, amounting to approximately £23,000, will be used for
general working capital purposes.
Application will be made for the new Ordinary Shares to be
admitted to trading on the Access segment of the AQSE Growth Market
and admission is expected to become effective on Monday,
23 May 2022.
Following this issue, the Company has 804,199,336 Ordinary
Shares in issue, each share carrying the right to one vote.
This figure of 804,199,336 Ordinary Shares may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company under the FCA's Disclosure and Transparency Rules.
-Ends-
The Directors of the Company accept responsibility for the
contents of this announcement.
ANANDA DEVELOPMENTS
PLC
Chief Executive Officer
Melissa Sturgess
Investor Relations
Jeremy Sturgess-Smith |
+44 (0) 7463 686
497
ir@anandadevelopments.com |
PETERHOUSE CAPITAL
LIMITED
Corporate Finance
Mark Anwyl
Corporate Broking
Lucy Williams
Duncan Vasey |
+44 (0)20 7469
0930 |
Market Abuse Regulation (MAR)
Disclosure
The information contained within this announcement is deemed by
the Company to constitute inside information. Upon the publication
of this announcement via a Regulatory Information Service, this
inside information is now considered to be in the public
domain.
About Ananda Developments
Ananda is an AQSE-listed medical cannabis company creating
UK-based operations to grow and provide carbon zero, consistent,
medical cannabis for the UK and international markets.
The UK medical cannabis market is predicted to be worth £450m by
2025 and the European market is predicted to be worth USD4.2bn by 2027.
Ananda, through its 50% owned subsidiary, DJT Plants Limited,
was granted a Home Office licence in May
2021 to grow >0.2% THC cannabis in a new research
facility to breed and stabilise 65 strains.
For more information, please visit:
https://anandadevelopments.com/